Language

Post-Covid-19 Epidemic Era, Precision Medicine Industry Development Trend Analysis Report 2023

Length- 111 Pages | Published Date - 2022-12-24 | Report Id- 7006
Single Licence $3900.00 | Enterprise License $6800.00 | Multiple Licensee $6800.00
Description Table of Contents Table of Figures
This report aims to provide a comprehensive presentation of the global market for Precision Medicine, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine.

The Precision Medicine market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Precision Medicine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Medicine manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Precision Medicine market size in 2022 is 7330.00 million US dollars, and it is expected to be 16821.81 million US dollars by 2029, with a compound annual growth rate of 12.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Precision Medicine market include Moderna, Inc. (U.S.), Personalis, Inc. (U.S.), CureVac SE (Germany), Celldex Therapeutics (U.S.), and BioNTech SE (Germany). The share of the top 3 players in the Precision Medicine market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of Precision Medicine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Alectinib accounted for XX% of Precision Medicine market in 2022. Osimertinib share of XX%.
Oncology accounted for XX% of the Precision Medicine market in 2022. Central Nervous System (CNS) Disorders accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapter 2: Analyzes the main companies in the Precision Medicine industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 3-5: Segmented the global Precision Medicine market by type, application and region. Analyze the revenue and sales of market segments from different perspectives.
Chapters 6-11: Provide North America, EMEA, China, Asia-Pacific and Latin America Precision Medicine market type, application, country and player market segmentation revenue data.
Chapter 12: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 13: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Moderna, Inc. (U.S.)
Personalis, Inc. (U.S.)
CureVac SE (Germany)
Celldex Therapeutics (U.S.)
BioNTech SE (Germany)
Advaxis, Inc. (U.S.)
Agenus Inc. (U.S.)
Immatics Biotechnologies GmbH (Germany)
Gritstone Oncology (U.S.)
ImmunityBio, Inc. (U.S.)
bioMérieux SA (France)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
F. Hoffmann-La Roche Ltd. (Switzerland)

Types list
Alectinib
Osimertinib
Mepolizumab
Aripiprazole Lauroxil,
Others

Application list
Oncology
Central Nervous System (CNS) Disorders
Immunology Disorders
Respiratory Disorders
Others

Contact US Anytime

Contact US Anytime

Find More

Post-Covid-19 Epidemic Era, Precision Medicine Industry Development Trend Analysis Report 2023

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top

Phone Number +86 195 30455980

Research Consulting reports@arstaresearch.com

Business Cooperation sales@arstaresearch.com

Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language
╳
English Español‎ Português Français Deutsch Русский Suomen Kieli Myanmar Tiếng Việt にほんご 한국어 Italiana हिन्दी Melayu ภาษาไทย اللغة العربية 中文(简体) 中文(繁体)

Sample Request

Message